1. Home
  2. CFFI vs ALLO Comparison

CFFI vs ALLO Comparison

Compare CFFI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFFI
  • ALLO
  • Stock Information
  • Founded
  • CFFI 1927
  • ALLO 2017
  • Country
  • CFFI United States
  • ALLO United States
  • Employees
  • CFFI N/A
  • ALLO N/A
  • Industry
  • CFFI Major Banks
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CFFI Finance
  • ALLO Health Care
  • Exchange
  • CFFI Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • CFFI 218.0M
  • ALLO 252.9M
  • IPO Year
  • CFFI 1998
  • ALLO 2018
  • Fundamental
  • Price
  • CFFI $67.65
  • ALLO $1.33
  • Analyst Decision
  • CFFI
  • ALLO Buy
  • Analyst Count
  • CFFI 0
  • ALLO 12
  • Target Price
  • CFFI N/A
  • ALLO $8.80
  • AVG Volume (30 Days)
  • CFFI 5.7K
  • ALLO 2.8M
  • Earning Date
  • CFFI 10-28-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • CFFI 2.72%
  • ALLO N/A
  • EPS Growth
  • CFFI 32.15
  • ALLO N/A
  • EPS
  • CFFI 7.56
  • ALLO N/A
  • Revenue
  • CFFI $122,075,000.00
  • ALLO N/A
  • Revenue This Year
  • CFFI N/A
  • ALLO N/A
  • Revenue Next Year
  • CFFI N/A
  • ALLO $100.00
  • P/E Ratio
  • CFFI $8.95
  • ALLO N/A
  • Revenue Growth
  • CFFI 7.42
  • ALLO N/A
  • 52 Week Low
  • CFFI $53.14
  • ALLO $0.86
  • 52 Week High
  • CFFI $89.90
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • CFFI 45.23
  • ALLO 65.07
  • Support Level
  • CFFI $65.50
  • ALLO $1.20
  • Resistance Level
  • CFFI $69.58
  • ALLO $1.31
  • Average True Range (ATR)
  • CFFI 1.56
  • ALLO 0.07
  • MACD
  • CFFI -0.45
  • ALLO 0.01
  • Stochastic Oscillator
  • CFFI 34.19
  • ALLO 95.24

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: